PTCT compared with GKOS: revenue, margins and what each company keeps, and the suppliers and customers both name

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

GKOSGlaukos Corp

Mkt capRevenueRevenue

Compare

PTCTPTC Therapeutics, Inc.

GKOSGlaukos Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PTCTPTC Therapeutics, Inc.

59.94▼−7.01%· post 59.99

Mkt cap$5.0BRevenue$361MQ2 FY26Revenue$1.7BFY25

GKOSGlaukos Corp

238.68▼−1.57%· post 237.12

ClosedOct 30 '26

Mkt cap$14.1BRevenue$211MQ3 FY26Revenue$507MFY25

Compare

ClosedOct 30 '26

PTCTPTC Therapeutics, Inc.

GKOSGlaukos Corp

59.94▼−7.01%post 59.99

Price

238.68▼−1.57%post 237.12

$5.0B

Mkt cap

$14.1B

Q2 FY26$361M

Revenue

$211MQ3 FY26

FY25$1.7B

Revenue

$507MFY25

PTCT59.94▼−7.01%vsGKOS238.68▼−1.57%ClosedOct 30 '26

Earnings history

last 4 reports each · paired by recencyMethod ›

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

Q1 FY26±9.4%▲+14.27%×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

GKOS

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.8%▲+33.65%×2.27

Q2 FY26±14.9%▲+4.24%×0.28

= impliedPTCT realized, solidGKOS realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

Q1 FY26

±10.6%

▲+22.84%

×2.15

Feb 18 '26±8.2%▲+13.47%×1.65